Number of Clinical Trials 2011
Explore the number of clinical trials conducted in various countries; critical for medical research and innovation.
Newer data is available: Number of Clinical Trials by country 2024 →
Where does your country rank? Pick it to see its position.
Related Health statistics
More ↓Interactive Map
Complete Data Rankings
- #1
United States
- #2
Germany
- #3
France
- #4
Canada
- #5
South Korea
- #6
United Kingdom
- #7
China
- #8
Denmark
- #9
Italy
- #10
Japan
Analysis: These countries represent the highest values in this dataset, showcasing significant scale and impact on global statistics.
- #115
Qatar
- #114
Papua New Guinea
- #113
Nigeria
- #112
Morocco
- #111
Republic of Moldova
- #110
Mauritius
- #109
Luxembourg
- #108
Kuwait
- #107
Cyprus
- #106
Costa Rica
Context: These countries or territories have the lowest values, often due to geographic size, administrative status, or specific characteristics.
Insights by country
Greece
In 2011, Greece ranked #26 globally with a total of 51 clinical trials. This figure is notable given that it places Greece above many regional peers, reflecting a robust interest in clinical research. The country's strategic location, along with a growing emphasis on healthcare innovation and research funding, has fostered an environment conducive to clinical trials.
Egypt
In 2011, Egypt ranked #33 globally with 30 clinical trials. This figure is notable when compared to the regional average, as many neighboring countries have fewer trials, indicating Egypt's relatively strong position in clinical research within the Middle East and North Africa. The country's strategic location, combined with a growing population and increasing investment in healthcare infrastructure, has fostered a conducive environment for clinical research initiatives.
Costa Rica
Costa Rica ranked #104 globally with 1 clinical trial in 2011. This number is significantly lower than that of regional neighbors, indicating a limited presence in clinical research compared to countries with more robust healthcare infrastructures. Factors contributing to this low figure include a smaller population and a focus on primary healthcare rather than extensive clinical research facilities.
Slovakia
In 2011, Slovakia ranked #63 globally with a total of 6 clinical trials. This figure is notably low compared to many Western European nations, which typically report higher numbers due to more established research infrastructures. The limited number of clinical trials in Slovakia can be attributed to factors such as a smaller population and less investment in medical research compared to its neighbors like Austria and the Czech Republic.
China
In 2011, China held the #7 position globally with a total of 257 clinical trials. This figure is notable compared to the global average, reflecting China's significant investment in medical research. Contributing factors include a large population that provides a diverse patient pool and governmental policies that encourage clinical research and development, positioning China as a key player in the global pharmaceutical landscape.
Azerbaijan
Azerbaijan ranked #99 globally with a total of 1 clinical trial in 2011. This number is significantly lower than many of its regional peers, reflecting a limited capacity for clinical research compared to countries with more developed healthcare systems. The low number of clinical trials can be attributed to Azerbaijan's nascent pharmaceutical industry and a healthcare infrastructure that has not yet fully embraced clinical research as a priority.
Afghanistan
In 2011, Afghanistan ranked #77 globally with a total of 2 clinical trials. This figure is notably low compared to many countries, reflecting limited research activity in the region. Factors contributing to this situation include ongoing conflict, a lack of infrastructure, and insufficient investment in healthcare and research initiatives. These challenges hinder the development of a robust clinical trial framework essential for advancing medical knowledge and improving public health.
Cambodia
Cambodia ranked #102 globally with a total of 1 clinical trial in 2011. This low number is significantly below the regional average, reflecting the country's emerging status in the clinical research landscape compared to more developed Southeast Asian nations. Contributing factors include limited infrastructure, a lack of funding for research initiatives, and ongoing challenges in healthcare development, which have hindered the growth of clinical trials in the country.
Lebanon
In 2011, Lebanon ranked #64 globally with a total of 5 clinical trials. This figure is notably lower than many regional neighbors, reflecting challenges in attracting international research investment. Contributing factors include Lebanon's complex political landscape and economic instability, which can deter foreign clinical research sponsors and limit local participation in global health studies.
Jamaica
In 2011, Jamaica ranked #87 globally with a total of 2 clinical trials. This figure is notably lower than many Caribbean neighbors, indicating limited engagement in clinical research activities. Contributing factors include Jamaica's smaller population and relatively lower investment in healthcare infrastructure compared to countries with more robust clinical trial frameworks.
Analysis & Context
In 2011, the United States led the world with the highest Number of Clinical Trials, totaling 4602, while the global range spanned from a minimum of 1 to a maximum of 4602. The worldwide median number of clinical trials was 7, highlighting significant disparities in research activity across countries.
Global Leaders in Clinical Trials
The dominance of the United States in clinical trials, with its staggering count of 4602, underscores the country's robust infrastructure for medical research and innovation. This is facilitated by a combination of factors including substantial funding, advanced healthcare systems, and a strong pharmaceutical industry presence. Germany and France follow as leading European nations with 492 and 456 trials, respectively, benefiting from similar structural advantages and a strong emphasis on scientific research.
Other countries in the top ten, such as Canada with 426 trials and South Korea with 341 trials, reflect significant investments in healthcare research, driven by both government and private sectors. These countries have established themselves as critical hubs for clinical research, attracting global pharmaceutical companies seeking to conduct trials in diverse populations.
Factors Behind Low Clinical Trial Numbers
At the opposite end of the spectrum, several countries, including Qatar, Trinidad and Tobago, and Nigeria, reported only 1 clinical trial each in 2011. The limited number in these nations can be attributed to factors such as smaller populations, limited healthcare infrastructure, and lower levels of investment in scientific research. Additionally, regulatory and bureaucratic hurdles often impede the ability to conduct clinical trials efficiently in these regions.
For countries like Nigeria, despite being Africa's largest economy, the disparity between economic potential and clinical research activity suggests a need for policy shifts and increased investment in medical research capabilities.
Year-Over-Year Trends and Significant Changes
The year-over-year analysis reveals notable changes in clinical trial numbers, with the United States experiencing the largest increase of +438 trials, marking a 10.5% rise. This growth is likely driven by continuous advancements in medical technology and increased funding for research initiatives. Similarly, South Korea saw a remarkable 53.6% increase, adding +119 trials, reflecting its strategic focus on becoming a leader in biotechnology and pharmaceuticals.
Conversely, Japan experienced a decline of -43 trials, equivalent to an -18.1% decrease, which may indicate shifts in research focus or challenges in trial approvals. Poland and Israel also reported decreases, with -16 and -15 trials, respectively, highlighting potential regulatory or economic factors impacting their clinical research outputs.
Implications for Global Health Innovation
The distribution of clinical trials across countries in 2011 reflects broader trends in global health innovation. Nations with strong research infrastructures, such as the United States, Germany, and France, continue to spearhead medical advancements, contributing to faster development of new treatments and therapies. This concentration of trials in developed nations also underscores the importance of international collaboration to address global health challenges.
For countries with fewer trials, enhancing research capabilities and creating conducive environments for clinical studies will be crucial in bridging the gap. This can lead to more equitable access to innovations and improved health outcomes worldwide. As global health issues become increasingly interconnected, the ability to conduct and benefit from clinical trials will play a pivotal role in addressing future medical challenges.
Frequently Asked Questions About Number of Clinical Trials in 2011
Which country conducted the most clinical trials in 2011?
The United States conducted the most clinical trials in 2011, with a total of 4,602 trials.
What was the average number of clinical trials conducted per country in 2011?
The average number of clinical trials conducted per country in 2011 was 86.43.
Which country conducted the fewest clinical trials in 2011?
Qatar conducted the fewest clinical trials in 2011, with only 1 trial.
What was the median number of clinical trials conducted per country in 2011?
The median number of clinical trials conducted per country in 2011 was 7.
How many countries conducted only 1 clinical trial in 2011?
Ten countries conducted only 1 clinical trial in 2011, including Qatar, Trinidad and Tobago, and Algeria.
Which countries were in the top 3 for the number of clinical trials conducted in 2011?
The top 3 countries for the number of clinical trials conducted in 2011 were the United States with 4,602 trials, Germany with 492 trials, and France with 456 trials.
Data Source
Number of clinical trials | ClinicalTrials.gov via Our World in Data
Data produced by ClinicalTrials.gov, compiled and published by Our World in Data as "Number of clinical trials".
Visit Data SourceCite this page
Geo Factbook. (n.d.). Number of Clinical Trials by Country, 2011. Retrieved November 16, 2026, from https://geofactbook.com/fact/number-of-clinical-trials/2011
The figures on this page come from Number of clinical trials | ClinicalTrials.gov via Our World in Data. For academic work, cite the original source as well.
›Embed this ranking on your site
Free to embed with attribution. Shows the top 10 countries and links back to the full ranking.